Independent register of U.S. FDA drug recalls · updated Oct 12, 2026
RxRecalls Get alerts

Class II drug recalls - moderate risk

Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.

14,535 recalls, newest first.

Class II · Moderate risk

Betamethasone Dipropionate Lotion USP

Failed Stability Specifications: lot did not meet specification for the Active Pharmaceutical Ingredient (API) particle test, which was determined through routine stability testing

Terminated Stability / shelf life Teligent Pharma, Inc. NDC 52565-023-29 D-0297-2022
Class II · Moderate risk

Strophanthus hisp 30X

Out-of-specification test results obtained for identification testing based on HPTLC analysis.

Terminated Failed specification Washington Homeopathic Products, Inc. D-0890-2021
Class II · Moderate risk

Strophanthus hisp 30X

Out-of-specification test results obtained for identification testing based on HPTLC analysis.

Terminated Failed specification Washington Homeopathic Products, Inc. D-0889-2021
Class II · Moderate risk

ZTE 1015 Formula

Out-of-specification test results obtained for identification testing based on HPTLC analysis.

Terminated Failed specification Washington Homeopathic Products, Inc. D-0888-2021
Class II · Moderate risk

ZTE-1035 Formula

Out-of-specification test results obtained for identification testing based on HPTLC analysis.

Terminated Failed specification Washington Homeopathic Products, Inc. D-0886-2021
Class II · Moderate risk

Viola od 6X

Out-of-specification test results obtained for identification testing based on HPTLC analysis.

Terminated Failed specification Washington Homeopathic Products, Inc. D-0878-2021
Class II · Moderate risk

Quebracho 4C

Out-of-specification test results obtained for identification testing based on HPTLC analysis.

Terminated Failed specification Washington Homeopathic Products, Inc. D-0877-2021
Class II · Moderate risk

Althaea 30X

Out-of-specification test results obtained for identification testing based on HPTLC analysis.

Terminated Failed specification Washington Homeopathic Products, Inc. D-0875-2021
Class II · Moderate risk

Althaea 6X

Out-of-specification test results obtained for identification testing based on HPTLC analysis.

Terminated Failed specification Washington Homeopathic Products, Inc. D-0874-2021
Class II · Moderate risk

Althaea 6X

Out-of-specification test results obtained for identification testing based on HPTLC analysis.

Terminated Failed specification Washington Homeopathic Products, Inc. D-0873-2021
Class II · Moderate risk

Althaea Officinalis 6X

Out-of-specification test results obtained for identification testing based on HPTLC analysis.

Terminated Failed specification Washington Homeopathic Products, Inc. D-0872-2021

Recalls by year